Catalyst Pharmaceutical CPRX Cash ratio
Cash ratio at other companies
Other financials
Where this comes from
Calculated from Catalyst Pharmaceutical’s reported figures.
Based on the most recent quarter.
The official record: Catalyst Pharmaceutical’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Catalyst Pharmaceutical's cash ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Catalyst Pharmaceutical's cash ratio?
- Catalyst Pharmaceutical (CPRX) reported cash ratio of 5.7× in Q1 2026.
- How has Catalyst Pharmaceutical's cash ratio changed year-over-year?
- Catalyst Pharmaceutical's cash ratio increased by 9.8% year-over-year, from 5.2× to 5.7×.
- What is the long-term trend for Catalyst Pharmaceutical's cash ratio?
- Over 5 years (2020 to 2025), Catalyst Pharmaceutical's cash ratio has grown at a -3.4% compound annual growth rate (CAGR), from 5.7× to 4.8×.
- What does cash ratio mean?
- Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.